entity

PROG

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PROG: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections

30Hypotheses

0Analyses

1Outgoing

0Incoming

18Experiments

0Debates

No AI portrait yet

Outgoing (1)

Target	Relation	Type	Str
neurodegenerative_disorders	treats	disease	0.80

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Elevated CSF/Serum Albumin Quotient Predicts Neurodegenerati	0.850	-	What blood-brain barrier permeability ch
TREM2-mTOR Co-Agonism for Metabolic Reprogramming	0.803	neurodegeneration	TREM2 agonism vs antagonism in DAM micro
GRN/progranulin lysosomal insufficiency across FTD, ALS-spec	0.756	multi	Cross-disease neurodegeneration mechanis
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming	0.748	neurodegeneration	Gene expression changes in aging mouse b
Metabolic Inflexibility Precedes Transcriptional Reprogrammi	0.735	neurodegeneration	What is the optimal therapeutic window f

Synthetic Biology BBB Endothelial Cell Reprogramming	0.727	neurodegeneration	Blood-brain barrier transport mechanisms
Metabolic Reprogramming to Reverse Senescence	0.720	-	Senescent cell clearance as neurodegener
EZH2-Mediated H3K27me3 Spreading in Senescent ALS Microglia	0.714	als	What are the mechanisms by which microgl
Microglial Purinergic Reprogramming	0.701	neurodegeneration	4R-tau strain-specific spreading pattern
NAD+ Decline and SIRT1 Deficiency Drive Epigenetic Reprogram	0.700	neurodegeneration	What molecular mechanisms drive microgli
Lysosomal Acidification Failure: Convergent GBA1/LAMP2A–medi	0.700	neurodegeneration	-
Mechanosensitive Ion Channel Reprogramming	0.700	neurodegeneration	Astrocyte reactivity subtypes in neurode
Metabolic Checkpoint Failure in NG2+ Oligodendrocyte Progeni	0.680	neurodegeneration	-
Metabolic Reprogramming via Microglial Glycolysis Inhibition	0.672	neurodegeneration	Synaptic pruning by microglia in early A
Partial Neuronal Reprogramming via Modified Yamanaka Cocktai	0.672	neurodegeneration	Epigenetic reprogramming in aging neuron
APOE4-Targeted Microglial Reprogramming via Anti-APOE4 Antib	0.670	neurodegeneration	Test Hypothesis Fixtures
OPC exhaustion and failed remyelination in progressive multi	0.670	neurodegeneration	Test
Circadian-Metabolic Microglial Reprogramming	0.662	-	Neuroinflammation and microglial priming
Chronic cGAS/STING Hyperactivation Drives Progressive Neurod	0.661	neuroinflammation	How does chronic cGAS/STING activation d
NeuroD1-Mediated Astrocyte Reprogramming Attenuates Neuroinf	0.650	neurodegeneration	epigenetic reprogramming aging neurons
Loss of Homeostatic Epigenetic Identity Reprograms Microglia	0.650	neurodegeneration	What molecular mechanisms drive microgli
Tau/MAP6 antagonism in neurodegeneration progression	0.650	neurodegeneration	-
IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral	0.648	neuroinflammation	How do B cells mechanistically orchestra
Epigenetic Reprogramming of Microglial Memory	0.647	alzheimers	Neuroinflammation and microglial priming
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem	0.646	neurodegeneration	Selective vulnerability of entorhinal co
Cell-Type Specific Metabolic Reprogramming	0.643	neurodegeneration	Cell type vulnerability in Alzheimers Di
SASP-Driven Microglial Metabolic Reprogramming in Synaptic P	0.643	neurodegeneration	Senolytic therapy for age-related neurod
Anti-inflammatory microglial reprogramming via cystatin-C/TR	0.640	neurodegeneration	Does the cancer-cystatin-C-TREM2 pathway
Heterogeneous astrocyte activation states differentially imp	0.640	alzheimers	SEA-AD Single-Cell Analysis: Cell-Type V
Astrocyte Metabolic Reprogramming via APOE4 Correction	0.636	neurodegeneration	Cell type vulnerability in Alzheimer's D

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (18)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
P2RY12 inhibition in atherosclerosis mouse model	validation	atherosclerosis	0.900	0.00	ApoE-deficient mice	proposed	N/A
VSMC cholesterol efflux and P2RY12 signaling	exploratory	atherosclerosis	0.900	0.00	cultured VSMCs	proposed	N/A
Leukocyte gene expression analysis in COVID-19 patients	exploratory	COVID-19	0.900	0.00	human leukocytes from COVID-19	proposed	N/A
P2RY12 regulation of autophagy in VSMCs	exploratory	atherosclerosis	0.900	0.00	cultured VSMCs	proposed	N/A
P2RY12-MTOR pathway interaction in VSMCs	exploratory	atherosclerosis	0.850	0.00	cultured VSMCs	proposed	N/A
In vivo autophagy modulation in atherosclerotic mice	validation	atherosclerosis	0.850	0.00	ApoE-deficient mice	proposed	N/A
s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice with engin	falsification	Neuroinflammation	0.400	0.50	mouse	proposed	$200,000
s:** - Compare uptake with/without magnetic particles using tight junc	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$120,000
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Therapy	validation	Parkinson's Disease	0.400	0.50	mouse	proposed	$280,000
AAV Serotype Comparison for LRRK2 Knockdown in PD	validation	Parkinson's Disease	0.400	0.50	mouse	proposed	$280,000
Blood-Based Biomarker Panel for Early AD Detection	clinical	Alzheimer's Disease	0.400	0.50	cell_line	proposed	$220,000
Blood-Brain Barrier Aging and Neurodegeneration — From Leakage to Neur	validation	Neurodegeneration	0.400	0.50	cell_line	proposed	$130,000
Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown	validation	Parkinson's Disease	0.400	0.50	mouse	proposed	$280,000
Vascular Contribution to Alzheimer's Disease — Beyond Amyloid	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$2,280,000
s:** - GPR32 knockout in microglia should worsen neuroinflammation if	falsification	Neuroinflammation	0.400	0.50	cell_line	proposed	$80,000
Proposed experiment from debate on Synaptic pruning by microglia in ea	falsification	Neuroinflammation	0.400	0.50	mouse	proposed	$240,000
DLB Treatment Response Biomarkers — Predicting Cholinesterase Inhibito	clinical	Neurodegeneration	0.400	0.50	human	proposed	$6,550,000
FTD Microglia Role: Protective vs Destructive Mechanism Study	validation	Neuroinflammation	0.400	0.50	human	proposed	$2,960,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Beyond Activation: Characterizing Microglial Functional Phenotypes. [PMID:34571885]	Lier J, Streit WJ, Bechmann I	Cells	2021	2
The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting auto [PMID:32160082]	Pi S, Mao L, Chen J, Shi H, Liu Y, Guo X	Autophagy	2021	2
NAD(+) metabolism, stemness, the immune response, and cancer. [PMID:33384409]	Navas LE, Carnero A	Signal Transduct Target Ther	2021	1
Convergence between Microglia and Peripheral Macrophages Phenotype during Develo [PMID:31818979]	Grassivaro F, Menon R, Acquaviva M, Otto	J Neurosci	2020	1
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Mic [PMID:28930663]	Krasemann S, Madore C, Cialic R, Baufeld	Immunity	2017	1
P2 purinergic receptors in systemic lupus erythematosus: from experimental findi [PMID:41825304]	Renaudineau Y, Brooks W	Current opinion in immunology	2026	0
Constitutive expression of CX3CR1-BAC-Cre introduces minimal off-target effects [PMID:41924777]	Mroue-Ruiz FH, Desai B, Garvin MM, Shehu	Biochemical and biophysical re	2026	0
[Advantageous therapeutic pathways and mechanisms of Jianpi Huogu Formula in tre [PMID:41814722]	Li T, Zhang C, Jia Y, Chen WH, Lin N, Zh	Zhongguo Zhong yao za zhi = Zh	2026	0
Differences in mRNA expression of neuroinflammation-related genes in the tempora [PMID:41843422]	Tan THL, McLean C, Christie M, Sanfilipp	Epileptic disorders : internat	2026	0
Clopidogrel Administration Impairs Neurovascular Unit Recovery and Exacerbates A [PMID:41898413]	Paul M, Paul JW, Hinwood M, Hood RJ, Mar	International journal of molec	2026	0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025	0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025	0
SIRT1 improves lactate homeostasis in the brain to alleviate parkinsonism via de [PMID:39128469]	Lian B, Zhang J, Yin X, Wang J, Li L et	Cell Rep Med	2024	0
SIRT1 improves lactate homeostasis in the brain to alleviate parkinsonism via de [PMID:39128469]	Lian B, Zhang J, Yin X, Wang J, Li L, Ju	Cell reports. Medicine	2024	0
Author Correction: Crystal structure of active CDK4-cyclin D and mechanistic bas [PMID:36577758]	Gharbi Severine Isabelle; Pelletier Laur	NPJ breast cancer	2022	0
The biology of beauty sleep. [PMID:35256810]	Jordan A Anderson; Jenny Tung	Nature ecology & evolution	2022	0
Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegen [PMID:34151764]	Kumar V, Kundu S, Singh A, Singh S	Curr Neuropharmacol	2022	0
Cathepsin S is a novel target for age-related dry eye. [PMID:34910926]	["Yu Z", "Li J", "Govindarajan G", "Hamm	Experimental eye research	2022	0
Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegen [PMID:34151764]	Kumar V, Kundu S, Singh A, Singh S	Current neuropharmacology	2022	0
Reducing acetylated tau is neuroprotective in brain injury. [PMID:33852912]	Shin MK, Vázquez-Rosa E, Koh Y, Dhar M,	Cell	2021	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning PROG in their description or question text

Synthetic Biology BBB Endothelial Cell Reprogramming

Score: 0.727 · neurodegeneration · 2026-04-02

## Mechanistic Overview Synthetic Biology BBB Endothelial Cell Reprogramming starts from the claim that modulating TFR1,

Metabolic Reprogramming to Reverse Senescence

Score: 0.720 · unknown disease · 2026-04-16

# Metabolic Reprogramming to Reverse Senescence in Neurodegeneration: A Mechanistic Hypothesis ## The Senescence Conund

EZH2-Mediated H3K27me3 Spreading in Senescent ALS Microglia Silences Neuroprotec

Score: 0.714 · als · 2026-04-26

The proposed hypothesis posits that in senescent microglia of amyotrophic lateral sclerosis (ALS) patients, the Polycomb

Microglial Purinergic Reprogramming

Score: 0.701 · neurodegeneration · 2026-04-02

## Mechanistic Overview Microglial Purinergic Reprogramming starts from the claim that modulating P2RY12 within the dise

NAD+ Decline and SIRT1 Deficiency Drive Epigenetic Reprogramming Toward Senescen

Score: 0.700 · neurodegeneration · 2026-04-22

## **Molecular Mechanism and Rationale** The molecular foundation of this hypothesis centers on the intricate relations

Mechanosensitive Ion Channel Reprogramming

Score: 0.700 · neurodegeneration · 2026-04-02

## Mechanistic Overview Mechanosensitive Ion Channel Reprogramming starts from the claim that modulating PIEZO1 and KCNK

Metabolic Reprogramming via Microglial Glycolysis Inhibition

Score: 0.672 · neurodegeneration · 2026-04-02

## Mechanistic Overview Metabolic Reprogramming via Microglial Glycolysis Inhibition starts from the claim that modulati

Partial Neuronal Reprogramming via Modified Yamanaka Cocktail

Score: 0.672 · neurodegeneration · 2026-04-02

## Mechanistic Overview Partial Neuronal Reprogramming via Modified Yamanaka Cocktail starts from the claim that modulat

APOE4-Targeted Microglial Reprogramming via Anti-APOE4 Antibodies

Score: 0.670 · neurodegeneration · 2026-04-26

APOE4 binds TREM2 with lower affinity than APOE3, driving microglia toward a neurodegenerative phenotype with failed DAM

OPC exhaustion and failed remyelination in progressive multiple sclerosis

Score: 0.670 · neurodegeneration · 2026-04-30

Repeated activation, inflammatory lesion exposure, aging, and senescence-like programs in oligodendrocyte precursor cell

Circadian-Metabolic Microglial Reprogramming

Score: 0.662 · unknown disease · 2026-04-04

## Mechanistic Overview Circadian-Metabolic Microglial Reprogramming starts from the claim that modulating CLOCK, BMAL1,

Chronic cGAS/STING Hyperactivation Drives Progressive Neurodegeneration Through

Score: 0.661 · neuroinflammation · 2026-04-21

## Mechanistic Overview Chronic cGAS/STING Hyperactivation Drives Progressive Neurodegeneration Through Sustained Type I

NeuroD1-Mediated Astrocyte Reprogramming Attenuates Neuroinflammation Through Ep

Score: 0.650 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The molecular foundation of this therapeutic approach centers on the dual functio